Eagle Pharmaceuticals To Present Additional Data from Phase 3 Trial Showing Sustained Response of Amisulpride For Rescue Treatment of Postoperative Nausea and Vomiting At Upcoming ASPAN 2024 National Conference
Author: Benzinga Newsdesk | April 15, 2024 07:25am